Serge Saxonov - Nov 22, 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Stock symbol
TXG
Transactions as of
Nov 22, 2022
Transactions value $
-$91,158
Form type
4
Date filed
11/23/2022, 04:02 PM
Previous filing
Sep 16, 2022
Next filing
Dec 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale -$26.9K -789 -0.08% $34.06 977K Nov 22, 2022 Direct F1
transaction TXG Class A Common Stock Sale -$64.3K -1.89K -0.19% $34.07 975K Nov 22, 2022 Direct F1
holding TXG Class A Common Stock 2.49K Nov 22, 2022 See footnote F2
holding TXG Class A Common Stock 90K Nov 22, 2022 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.